Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

JDOC vs HIAHX overlap: 62% of top holdings shared

Bottom line

How much do JDOC and HIAHX overlap?

62% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 58.0% of JDOC's assets and 57.8% of HIAHX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

JDOCHIAHX
Weight overlap (top 25)62%
Shared holdings17
Weight in shared holdings58.0%57.8%
Total positions6179
Expense ratio0.65%0.94%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings JDOC and HIAHX have in common

Holding% of JDOC% of HIAHXOverlap
AbbVie, Inc.7.85%3.43%3.43%
Eli Lilly & Co.7.76%12.47%7.76%
UnitedHealth Group, Inc.5.85%4.72%4.72%
Merck & Co., Inc.4.82%6.60%4.82%
Johnson & Johnson4.82%6.63%4.82%
Thermo Fisher Scientific, Inc.3.73%1.64%1.64%
Abbott Laboratories3.11%2.10%2.10%
CVS Health Corp.2.83%2.93%2.83%
GSK plc2.47%1.21%1.21%
Stryker Corp.2.23%1.17%1.17%
Danaher Corp.2.16%2.65%2.16%
Cencora, Inc.2.07%2.07%2.07%
Intuitive Surgical, Inc.1.93%2.99%1.93%
Edwards Lifesciences Corp.1.73%2.42%1.73%
Regeneron Pharmaceuticals, Inc.1.60%1.52%1.52%
Biogen, Inc.1.56%1.41%1.41%
Cardinal Health, Inc.1.51%1.81%1.51%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in JDOC

  1. AstraZeneca plc — 3.76%
  2. Bristol-Myers Squibb Co. — 3.57%
  3. Roche Holding AG — 2.82%
  4. Novo Nordisk A/S — 2.61%
  5. Argenx SE — 2.06%
  6. IQVIA Holdings, Inc. — 1.71%
  7. Teva Pharmaceutical Industries Ltd. — 1.60%
  8. Novartis AG — 1.60%

Only in HIAHX

  1. Elevance Health Inc — 2.96%
  2. Vertex Pharmaceuticals Inc — 2.69%
  3. HCA Healthcare Inc — 1.60%
  4. Agilent Technologies Inc — 1.36%
  5. Boston Scientific Corp — 1.19%
  6. Centene Corp — 1.16%
  7. Medtronic PLC — 1.02%
  8. United Therapeutics Corp — 0.96%

Asset mix

Asset typeJDOCHIAHX
Stocks99.2%96.8%
Repurchase agreements—0.7%
Cash & short-term funds—0.4%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryJDOCHIAHX
US75.2%87.9%
GB6.2%2.3%
CH4.4%0.6%
DK4.0%0.8%
JP2.5%—
NL2.4%1.8%
IE0.4%2.3%
DE1.9%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do JDOC and HIAHX overlap?
About 62% by weight. 17 securities appear in both funds' top 25 holdings; they make up 58.0% of JDOC's assets and 57.8% of HIAHX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do JDOC and HIAHX have in common?
The largest shared holdings are Eli Lilly & Co., Merck & Co., Inc., Johnson & Johnson, UnitedHealth Group, Inc., AbbVie, Inc..
Should I own both JDOC and HIAHX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, JDOC or HIAHX?
HIAHX is broader, with 79 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.